Press Releases
NYSE: VZLA TSX-V: VZLA
VANCOUVER, BC, May 22, 2024 /PRNewswire/ - Vizsla Silver Corp. (TSXV: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla" or the "Company") is pleased to report results from 16 new drillholes targeting the Napoleon Vein, at its 100%-owned flagship Panuco silver-gold project ("Panuco") located in Mexico. The new drill results are centered on the western portion of the district and are part of Vizsla's ongoing +30,000 metre resource conversion and... (continue reading...)
ST. HELENA, Calif., May 22, 2024 /PRNewswire/ -- Embrace the adventure, celebration and magic of the summer season with the newest wine releases from Jayson Woodbridge's Summer Dreams.
Following the release of his highly acclaimed Hundred Acre wines, the release of Summer Dreams Chardonnay, Sauvignon Blanc, Rosé, and four Pinot Noirs marks... (continue reading...)
ROCKVILLE, Md., May 22, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024.
... (continue reading...)Q1 2024 Overview
- Net revenue of $1.5 billion decreased 1.7 percent year over year
- Comparable sales declined 1.2 percent year over year and increased 4.1 percent on a two-year basis
- GAAP net loss of $46.5 million, or $(0.17) per share, compared to GAAP net loss of $1.9 million, or $(0.01) per share in the prior year
- Adjusted Net Income1 of $(11.8) million, or $(0.04) per share, compared to $14.9 million, or $0.06 per share in the prior year
- Adjusted EBITDA1 of $75.6... (continue reading...)
VICTORIA, BC, May 22, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet need, today announced that it will host a virtual key opinion leader ("KOL") event on Wednesday, May 29, 2024, at 10:00 AM ET.
To register, please click here.
The event will feature... (continue reading...)
More Press Releases
View Older Stories-
VNET to Announce Unaudited First Quarter 2024 Financial Results on May 29, 2024
-
Media Advisory: OFL and Ontario NDP to launch campaign to regulate heat stress in Ontario workplaces
-
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY
-
In Our UNITED Era: Walk ALS Chicago on June 1st
-
YouTube Phenomenon, Skibidi Toilet, Makes a Plunge to the Toy Aisle with Bonkers Toys and Invisible Narratives Licensing Partnership
-
Medsien Named Veradigm Connect's App of the Month, Expands Relationship to Offer Unparalleled Remote Care Management Solutions
-
Analog Devices Reports Fiscal Second Quarter 2024 Financial Results
-
Quadient Positioned as The Leader in the 2024 SPARK Matrix™ for Accounts Receivable Applications by Quadrant Knowledge Solutions
-
Grounded Lithium Reports First Quarter 2024 Financial and Operating Results
-
Harts Plumbers, Electricians and HVAC Technicians and the Tacoma Rainiers continue honoring service members with 2024 Hometown Heroes program
-
Aura Announces Acquisition of Pé Quente and Pezão Projects, Aiming to Add Mineral Resources and Reserves to the Nearby Matupá Project
-
Siyata Mobile Expands SD7 Rollout at Baha Mar Resort
-
Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy
-
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual Oncology Innovation Forum
-
Interplay Learning Names Jim Clor as VP of Education and Workforce Development
-
Average Age of Vehicles in the US Continues to Rise: 12.6 years in 2024, according to S&P Global Mobility
-
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
-
Shur-Co Acquires AB Airbags
-
Avaneer Health Announces the Launch of its Coverage Direct Solution
-
AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024
-
SES AI to Present at Two Investor Conferences in June
-
New Survey Finds Two in Five Canadian Employees Cannot Afford Access to Mental Health Services
-
BioLineRx to Report First Quarter 2024 Results on May 28, 2024
-
Meatable Appoints U.S.-Based Meat Industry Veteran Jeff Tripician as New CEO
-
Electra Files First Quarter 2024 Financial Reports
-
Pitney Bowes Announces Leadership Transition and New Initiatives to Accelerate Value Creation
-
WalkMe Ltd. Announces First Quarter 2024 Financial Results
-
Signet and De Beers collaborate to highlight the unique attributes of natural diamonds to a new generation of U.S. couples
-
EX.CO Announces New Video Solution for Ad Management Partners
-
Arbe Announces Q1 2024 Financial Results
-
EA SPORTS FC™ FUTURES Announces Partnership With UNICEF and Shares Year One Impact
-
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results
-
SugarCRM Acquires sales-i to Enhance Customer Sales Profitability, Drive Intelligent Account Management
-
SatixFy and SCOTTY Group Partner to Supply In-Flight Connectivity Terminals
-
Multi-market access with the upgrade of the trading platform Devexperts
-
Bidgely Accelerates Growth with Former Tesla Renewable Energy Leader Tyler Moragne as Chief Strategy Officer
-
Laser Photonics and Incredible Supply & Logistics Co-Host Exhibit Booth at NCMS Technology Showcase at Norfolk Naval Shipyard
-
ReposiTrak Adds 20 New Dairy Suppliers to the Queue to the Rapidly Expanding Food Traceability Network
-
Chad Walter Joins DiningRD as Chief Financial Officer
-
CUJO AI Hits 3 Billion Devices, With EE Also Revealed As Latest Client
-
Wellfit Technologies Showcases Innovative Financing Solutions at Premier Dental Conferences
-
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
-
Sierra Metals Inc. Enters Into a Binding Agreement With Silverco Mining Corp. to Sell Its Cusi Project in Mexico
-
Promega Highlights Progress in Sustainability, Employee Wellbeing and Community Engagement in 2024 Corporate Responsibility Report
-
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024
-
U Power Limited's UOTTA Heavy Truck Battery Swapping Technology is Expected to Enter the Peruvian Market
-
Denodo Redoubles Focus on Energy and Utilities
-
CI Global Asset Management Announces Risk Rating Change for CI ICBCCS S&P China 500 Index ETF
-
Saadiyat Cultural District Abu Dhabi: One of the greatest concentrations of cultural institutions is on track for 2025 completion, showcasing Abu Dhabi's commitment to culture
-
Pebblebrook Hotel Trust Provides Operating Update